These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7049933)

  • 41. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
    Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
    J Hypertens; 1994 Jun; 12(6):653-61. PubMed ID: 7963490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The kallikrein/kinin system in ocular function.
    Webb JG
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):539-43. PubMed ID: 22136090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal kallikrein: its localization and possible role in renal function.
    Carretero OA; Scicli AG
    Fed Proc; 1976 Feb; 35(2):194-8. PubMed ID: 1248653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Kolloch R; Zywzok W; Krück F
    Klin Wochenschr; 1980 Jan; 58(1):37-42. PubMed ID: 6900133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary kininogen: a possible regulator of kinin formation in normal individuals and subjects with essential hypertension, end-stage renal and liver disease.
    Weinberg MS; Trebbin WM; Solomon RJ
    Adv Exp Med Biol; 1986; 198 Pt A():119-25. PubMed ID: 3812087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thiazide induced hypotension: the role of plasma volume reduction and the urinary kallikrein system.
    Solomon RJ; Stillman N; Weinberg MS
    Adv Exp Med Biol; 1986; 198 Pt B():243-51. PubMed ID: 3544727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The renal kallikrein-kinin system and the regulation of salt and water excretion.
    Mills IH; Macfarlane NA; Ward PE; Obika LF
    Fed Proc; 1976 Feb; 35(2):181-8. PubMed ID: 765162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
    Wolf WC; Yoshida H; Agata J; Chao L; Chao J
    Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocrine mechanisms in the pathogenesis of essential hypertension. III. Special reference on the interrelations between the prostaglandin and kallikrein-kinin systems.
    Păuşescu E
    Physiologie; 1981; 18(2):141-52. PubMed ID: 6791173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of renal prostaglandins, renin-angiotensin system and renal kallikrein-kinin system in human hypertension.
    Abe K; Tsunoda K; Sato M; Omata K; Yasujima M; Yoshinaga K
    Agents Actions Suppl; 1987; 22():215-20. PubMed ID: 3324710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal venous output of kinins in patients with hypertension and unilateral renal artery stenosis.
    Hulthén UL; Lecerof H; Hökfelt B
    Acta Med Scand; 1977; 202(3):189-91. PubMed ID: 910636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal kinin antagonism does not impair pressure-induced natriuresis.
    Strick DM; Fiksen-Olsen MJ; Carretero OA; Romero JC
    Am J Physiol; 1992 Jul; 263(1 Pt 2):F77-82. PubMed ID: 1636746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
    Chao J; Zhang JJ; Lin KF; Chao L
    Hum Gene Ther; 1998 Jan; 9(1):21-31. PubMed ID: 9458239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kallikrein, kininogen and kinins in control of blood pressure.
    Mills IH
    Nephron; 1979; 23(2-3):61-71. PubMed ID: 375113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The kallikrein-kinin system in pregnant women with gestosis before and during complex therapy].
    Strizhakov AN; Bol'shakova TD; Kuznetsov VA; Starkova TG
    Akush Ginekol (Mosk); 1989 May; (5):33-7. PubMed ID: 2742064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension.
    Katori M; Majima M
    Crit Rev Clin Lab Sci; 2003 Feb; 40(1):43-115. PubMed ID: 12627748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal kallikrein-kinin, prostaglandin E2, and dopamine systems in young normotensive subjects with a family history of essential hypertension.
    Shimamoto K; Ura N; Nishimura M; Iimura O
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S70-4. PubMed ID: 8141169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of kinins and prostacyclin in blood pressure regulation.
    Bönner G
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():15-9. PubMed ID: 2514656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of ureteral occlusion and renal venous constriction on kidney kallikrein-kinin and prostaglandin systems in dogs.
    Olsen UB
    Acta Physiol Scand; 1978 Dec; 104(4):443-52. PubMed ID: 726937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.